Aaron oversees biology for GE Healthcare Cell and Gene Therapy and helped found and currently directs BRIDGE@CCRM. BRIDGE@CCRM is a $40M GE collaboration with the Centre for Commercialization of Regenerative Medicine (CCRM) and the Government of Canada to create a Centre for Advanced Therapeutic Cell Technologies to offer technology and process development services for cell and gene therapy manufacturers. Prior to his current role, Aaron oversaw Research and Portfolio Management for the cell therapy division of GE and has previously served in a variety of management and scientific positions within GE Healthcare and GE Global Research. Aaron earned his Ph.D. in Materials Science and Engineering from Rensselaer Polytechnic Institute focusing on tissue engineering and mesenchymal stem cells and his Bachelor of Science in Engineering in Chemical and Biological Engineering from Princeton University.